Brendan Smith
Keine laufenden Positionen mehr
Vermögen: 345 708 $ am 31.03.2024
Profil
Derzeit ist Brendan Smith Senior VP, Chief Financial & Accounting Officer bei CRISPR Therapeutics AG. In der Vergangenheit war Herr Smith Chief Financial Officer & Head-Corporate Strategy bei Translate Bio, Inc. und Partner & Associate Director bei The Boston Consulting Group, Inc. Er erwarb einen Bachelor-Abschluss am Worcester Polytechnic Institute und einen MBA an der Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG
0,01% | 31.03.2023 | 5 072 ( 0,01% ) | 345 708 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Brendan Smith
| Unternehmen | Position | Ende |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director of Finance/CFO | 14.03.2023 |
| TRANSLATE BIO, INC. | Director of Finance/CFO | 14.09.2021 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.03.2021 |
| Pfizer AG | Director/Board Member | - |
Ausbildung von Brendan Smith
| Worcester Polytechnic Institute | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
| Pfizer AG |
